ArticleCancer medicine2020

TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti-CTLA4 treatment.

Huahua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.